1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Progesterone Receptor Positive Tumor: new trials by email Literature Review of Progesterone Receptor Positive Tumor trials Research Report on Progesterone Receptor Positive Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer Dietary supplementation with fish oil., Dietary supplementation with vegetable oil - Metastatic Breast Cancer, Progesterone Receptor Positive Tumor | Phase 3 | Terminated | University Hospital, Tours | 65 | 2012-02-01 | 2015-07-29 |
| Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer Exemestane, Laboratory Biomarker Analysis, Oophorectomy - Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor | Phase 3 | Completed | ETOP IBCSG Partners Foundation | 3066 | 2003-12-17 | 2026-08-26 |
Breast Neoplasms (2)
Breast Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2)
Dietary Supplements (1) · Fish Oils (1) · Gonadotropin-Releasing Hormone (1) · Ovariectomy (1) · Plant Oils (1) · Radiation (1) · Radiotherapy (1) · Tamoxifen (1) · Triptorelin Pamoate (1) · exemestane (1)
ETOP IBCSG Partners Foundation (1) · University Hospital, Tours (1)
Canada (1) · France (1) · Switzerland (1) · United States (1)
Gini Fleming (1) · Philippe Bougnoux, MD, PhD (1)
PMID 24095609, PMID 24881463, PMID 25495490, PMID 26092816, PMID 27022111, PMID 27044936, PMID 28911092, PMID 29863451, PMID 31618131, PMID 36493334, PMID 36521078, PMID 40986647, PMID 41637791
2004 (1), U24CA075362 (1)